CLINICAL FEATURES OF PATIENT WITH SEVERE ACQUIRED ADAMTS13 DEFICIENCY IN THROMBOTIC THROMBOCYTOPENIC PURPURA

被引：0
|
作者：
Oh, D. [1 ]
Kim, I. -H. [2 ]
Jung, C. -W. [3 ]
Le, J-W. [4 ]
Lee, H. G. [5 ]
Sohn, S. K. [6 ]
机构：
[1] CHA Univ, Internal Med, Songnam, South Korea
[2] Seoul Natl Univ, Coll Med, Internal Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Internal Med, Seoul, South Korea
[4] Catholic Univ, Coll Med, Internal Med, Seoul, South Korea
[5] Konkuk Univ, Sch Med, Internal Med, Seoul, South Korea
[6] Kyungpook Natl Univ, Internal Med, Daegu, South Korea
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1407
引用
收藏
页码：565 / 565
页数：1
相关论文
共 50 条
  • [21] Infection and Its Role in the Clinical Course of Idiopathic Thrombotic Thrombocytopenic Purpura Associated with Severe ADAMTS13 Deficiency
    Hussein, Eiman
    Teruya, Jun
    TRANSFUSION, 2017, 57 : 98A - 98A
  • [22] Novel ADAMTS13 mutations in a patient with congenital thrombotic thrombocytopenic purpura
    Wang, Zhitao
    Zhang, Xinhui
    Lu, Xueqin
    Peng, Peng
    Wang, Huiru
    Feng, Shanglong
    Zhou, Li
    HEMATOLOGY, 2023, 28 (01)
  • [23] Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura
    Page, Evaren E.
    Hovinga, Johanna A. Kremer
    Terrell, Deirdra R.
    Vesely, Sara K.
    George, James N.
    BLOOD, 2016, 128 (17) : 2175 - 2178
  • [24] Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura
    Tersteeg, Claudia
    Schiviz, Alexandra
    De Meyer, Simon F.
    Plaimauer, Barbara
    Scheiflinger, Friedrich
    Rottensteiner, Hanspeter
    Vanhoorelbeke, Karen
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (11) : 2336 - 2342
  • [25] Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura
    Yamaguchi, Yusuke
    Moriki, Takanori
    Igari, Atsuko
    Nakagawa, Terumichi
    Wada, Hideo
    Matsumoto, Masanori
    Fujimura, Yoshihiro
    Murata, Mitsuru
    THROMBOSIS RESEARCH, 2011, 128 (02) : 169 - 173
  • [26] Recombinant ADAMTS13 as an effective therapy for acquired thrombotic thrombocytopenic purpura in rats
    Tersteeg, C.
    Schiviz, A.
    Plaimauer, B.
    De Meyer, S. F.
    Scheiflinger, F.
    Vanhoorelbeke, K.
    Rottensteiner, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 152 - 152
  • [27] Thrombotic Thrombocytopenic Purpura - The Role of ADAMTS13 Assay in Clinical Practice
    Durakovic, Nadira
    Radonic, Radovan
    Gasparovic, Vladimir
    COLLEGIUM ANTROPOLOGICUM, 2010, 34 (03) : 1087 - 1091
  • [28] Deficiency of ADAMTS 13 in thrombotic thrombocytopenic purpura
    Tsai, HM
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 2) : 132 - 138
  • [29] Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura
    Bendapudi, Pavan K.
    Foy, Brody H.
    Mueller, Sarah B.
    Liu, Jun
    Feingold, Louis M.
    Burke, Kristen E.
    Cruz, Wendy
    Chen, Maria Y.
    Lau, Emily S.
    Goldberg, Rachel L.
    Tatake, Ishan
    Wilkinson, Shelby C.
    Carney, Brian J.
    Stone, James R.
    Park, Doyun
    Avelino, Alzira R.
    Hassan, Sajjad
    Andrzejewski, Chester
    Ruby, Kristen N.
    Friedman, Kenneth D.
    Brunker, Patricia A. R.
    Leaf, Rebecca K.
    Higgins, John
    Dzik, Walter H.
    Stefely, Jonathan A.
    Makar, Robert S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (18): : 1690 - 1698
  • [30] Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura
    Wendt, Ralph
    Voelker, Linus A.
    Brinkkoetter, Paul T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (04): : 382 - 384
12345